# Randomized Controlled Trial of the Meaning-Making Intervention (MMi) In Newly Diagnosed Advanced Cancer

> **NCT02583932** · PHASE3 · COMPLETED · sponsor: **Jewish General Hospital** · enrollment: 179 (actual)

## Conditions studied

- Advanced Cancer

## Interventions

- **DRUG:** Meaning-Making intervention (MMi)
- **BEHAVIORAL:** Empathic Visitor

## Key facts

- **NCT ID:** NCT02583932
- **Lead sponsor:** Jewish General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2020-08
- **Final completion:** 2020-08
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2021-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02583932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02583932, "Randomized Controlled Trial of the Meaning-Making Intervention (MMi) In Newly Diagnosed Advanced Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02583932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*